First-trimester Down syndrome screening: Component analytes and timing for optimal performance

Seminars in Perinatology

Volumn 29, Issue 4, 2005, Pages 195-202

  Wenstrom, Katharine D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

First trimester Down syndrome screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; CROWN RUMP LENGTH; DIAGNOSTIC ACCURACY; DOWN SYNDROME; ECHOGRAPHY; FACIAL BONE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; PERFORMANCE; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

DOWN SYNDROME; FEMALE; FETAL DISEASES; FETUS; HUMANS; INFANT, NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 23644433190     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.06.002     Document Type: Conference Paper

References (52)

1. N.J. Wald, C. Rodeck, A.K. Hackshaw First and second trimester antenatal screening for Down's syndrome the results of the Surum, Urine, and Ultrasound Screening Study (SURUSS) J Med Screen 10 2003 56 104
2. F.D. Malone, N.J. Wald, J.A. Canick First and second trimester evaluation of risk (FASTER) trial Principal results of the NICHD Down syndrome screening study Am J Obstet Gynecol 189 2003 S56
3. N.J. Wald, C. Rodeck, A.K. Hackshaw, A. Rudnicka SURRUS in persepctive BJOG 111 2004 521 531
4. B. Hall Mongolism in newborn infants Clin Pediatr 5 1966 4
5. B.R. Benacerraf, V.A. Barss, L.A. Laboda A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome Am J Obstet Gynecol 151 1985 1078 1079
6. B.R. Benacerraf, F.D. Frigoletto, L.A. Laboda Sonographic diagnosis of Down syndrome in the second trimester Am J Obstet Gynecol 153 1985 49 52
7. K.H. Nicolaides, G. Azar, D. Byrne Fetal nuchal translucency ultrasound screening for chromosomal defects in first trimester of pregnancy Br Med J 304 1992 867 870
8. R.J.M. Snijders, P. Noble, N. Sebire UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
9. K. Schuchter, E. Hafner, G. Stangl The first trimester "combined test" for the detection of Down syndrome pregnancies in 4939 unselected pregnancies Prenatal Diagn 22 2002 211 215
10. K. Spencer Accuracy of Down syndrome risks produced in a first-trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry Prenat Diagn 22 2002 244 246
11. K.H. Nicolaides, V. Heath, S. Cicero Increased fetal nuchal translucency at 11-14 weeks Prenat Diagn 22 2002 308 315
12. R. Wapner, E. Thom, J.L. Simpson First-trimester screening for trisomies 21 and 18 N Engl J Med 349 2003 1405 1413
13. T.L. Stewart, F.D. Malone First trimester screening for aneuploidy nuchal translucency sonography Semin Perinatol 23 1999 369 381
14. F.D. Malone, M.E. D'Alton Society for Maternal-Fetal Medicine First trimester sonographic screening for Down syndrome Obstet Gynecol 102 2003 1066 1079
15. P.P. Pandya, R.J. Snijders, S.P. Johnson Screening for fetal trisomies by maternal age and fetal translucency thickness at 10 to 14 weeks of gestation Br J Obstet Gynaecol 102 1995 957 962
16. K. Spencer, R. Bindra, A.B.J. Nix Delta-NT or NT MoM which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 22 2003 142 148
17. N.J. Wald, A.K. Hackshaw Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome Prenat Diagn 17 1997 9821 9829
18. R. Biagiotti, E. Periti, L. Brizzi Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21 Ultrasound Obstet Gynecol 9 1997 248 252
19. J.M. Braithwaite, R.W. Morris, D.L. Economides Nuchal translucency measurements frequency distribution and changes with gestation in a general population Br J Obstet Gynaecol 103 1996 1201 1204
20. H. Logghe, H. Cuckle, I. Sehmi Centre-specific ultrasound nuchal translucency medians needed for Down syndrome screening Prenat Diagn 23 2003 389 392
21. K.H. Nicolaides, R.J. Snijders, H.S. Cuckle Correct estimation of parameters for ultrasound nuchal translucency screening Prenat Diagn 18 1998 519 521
22. F.D. Malone, N.J. Wald, J.A. Canick Use of overall population, center-specific, and sonographer-specific nuchal translucency medians in Down syndrome screening which is best? (Results from the faster trial) Am J Obstet Gynecol 189 2003 6
23. N.J. Wald, A. Kennard, A. Hackshaw Antenatal screening for Down's syndrome J Med Screen 4 1997 181 246
24. G.J. Knight, G.E. Palomaki, L.M. Neveux hCG and the free β-subunit as screening tests for Down syndrome Prenat Diagn 18 1998 235 245
25. S. Cicero, P. Curcio, A. Papagerghiou Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation an observational study Lancet 358 2001 1665 1667
26. S. Cicero, R. Bindra, G. Rembouskos Fetal nasal bone in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation J Matern Fetal Neonatal Med 11 2002 400 402
27. S. Cicero, D. Longo, G. Rembouskos Absent nasal bone at 11-14 weeks of gestation chromosomal defects Ultrasound Obstet Gynecol 22 2003 31 35
28. M.A. Zoppi, R.M. Ibba, C. Axiana Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies Prenat Diagn 23 2003 496 500
29. F. Orlandi, C.M. Bilardo, M. Campogrande Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment Ultrasound Obstet Gynecol 22 2003 36 39
30. S. Cicero, R. Bindra, G. Rembouskos Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks Prenat Diagn 23 2003 306 310
31. F.D. Malone, R.H. Ball, D.A. Nyberg First-trimester nasal bone evaluation for aneuploidy in an unselected general population results from the Faster trial Am J Obstet Gynecol 189 2003 S79
32. J.D. Sonek, D. McKenna, D. Webb Nasal bone length throughout gestation normal ranges based on 3537 fetal ultrasound measurements Ultrasound Obstet Gynecol 21 2003 152 155
33. A. Tuxen, J.W. Keeling, I. Reintoft A histological and radiological investigation of the nasal bone in fetuses with Down syndrome Ultrasound Obstet Gynecol 22 2003 22 26
34. F. Guis, Y. Ville, S. Doumerc Ultrasound evaluation of the length of the fetal nasal bones throughout gestation Ultrasound Obstet Gynecol 5 1995 304 307
35. S. Cicero, V. Dezerega, E. Andrade Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks Ultrasound Obstet Gynecol 22 2003 135 137
36. M.V. Senat, J.P. Bernard, M. Boulvaion Intra- and interoperator variability in fetal nasal bone assessment at 11-14 weeks of gestation Ultrasound Obstet Gynecol 22 2003 138 141
37. S. Minderer, K.P. Gloning, W. Henrich The nasal bone in fetuses with trisomy 21 sonographic versus pathomorphological findings Ultrasound Obstet Gynecol 22 2003 16 21
38. V. Bunduki, R. Ruano, J. Miguelez Fetal nasal bone length reference range and clinical application in ultrasound screening for trisomy 21 Ultrasound Obstet Gynecol 21 2003 156 160
39. K.H. Nicolaides Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities Am J Obstet Gynecol 191 2004 45 67
40. J.A. Hyett, M.L. Brizot, C.S. Von Kaisenberg Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses Obstet Gynecol 87 1996 506 510
41. S.K. Hendricks, T.K. Sorenson, E.R. Baker Trisomy 21, fetal hydrops, and anemia prenatal diagnosis of transient myeloproliferative disorder? Obstet Gynecol 82 1993 703 705
42. F.A. Chervenak, G. Isaacson, K.J. Blakemore Fetal cystic hygroma. Cause and natural history N Engl J Med 309 1983 822 825
43. E.B. Clark Neck web and congenital heart defects a pathogenic association in 45 X-O Turner syndrome? Teratology 29 1984 355 361
44. R.V. Lacro, K.L. Jones, K. Benirschke Coarctation of the aorta in Turner syndrome a pathologic study of fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia Pediatrics 81 1988 445 451
45. L.D. Berdahl, K.D. Wenstrom, J.W. Hanson Web neck anomaly and its association with congenital heart disease Am J Med Genet 56 1995 304 307
46. J. Hyett, M. Perdu, G. Sharland Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation population based cohort study Br Med J 318 1999 81 85
47. T. Ghi, I.C. Huggon, N. Zosmer Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype Ultrasound Obstet Gynecol 18 2001 610 614
48. L.L. Simpson, F. Malone, D. Bianchi Nuchal translucency and the risk of congenital heart disease a population-based screening study (the Faster trial) SMFM Abstracts Am J Obstet Gynecol 191 2004 S3
49. J.M. Simpson, G.K. Sharland Nuchal translucency and congenital heart defects heart failure or not? Ultrasound Obstet Gynecol 16 2000 30 36
50. G. Makrydimas, A. Sotiriadis, J. Ioannidis Screening performance of first-trimester nuchal translucency for major cardiac defects a meta-analysis Am J Obstet Gynecol 189 2003 1330 1335
51. E. Mavrides, F. Cobian-Sanchez, A. Tekay Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects Ultrasound Obstet Gynecol 17 2001 106 110
52. P.P. Pandya, R.J. Snijders, S.P. Johnson, B.M. DeLourdes, K.H. Nicolaides Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation Br J Obstet Gynecol 17 2001 106 110